Sanofi (SNY) Unit Says MACI Met Co-Primary Endpoint vs. Microfracture in Phase 3 Trial
Go back to Sanofi (SNY) Unit Says MACI Met Co-Primary Endpoint vs. Microfracture in Phase 3 Trial| SANOFI (NASDAQ: SNY) | Delayed: 45.83 +0.86 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.97 | 52 Week High | $44.76 | |||
| Open | $45.42 | 52 Week Low | $36.81 | |||
| Day High | $46.02 | P/E | N/A | |||
| Day Low | $45.42 | EPS | $0.00 | |||
| Volume | 836,730 | |||||
